(MENAFN- NewsBytes) The World Health Organization (WHO) has once again postponed granting emergency approval to COVAXIN, India's indigenous vaccine against the coronavirus. The global health body has sought more technical data from Bharat Biotech to conduct a final "risk-benefit assessment." The technical advisory group of WHO will now meet on November 3 for a final assessment. Here are more details on this.
Context Why does this story matter?
A WHO approval for COVAXIN will help the vaccine gain wider acceptance around the world. It will allow Bharat Biotech to start widely exporting the vaccine and let people fully vaccinated with the jab to travel abroad without facing restrictions. Notably, many Indians, especially students who received this vaccine, have been facing issues in traveling abroad.
MENAFN27102021000165011035ID1103052549
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.